Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phosphatases and tumorigenesis

R Parsons1

  • 1Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

Current Opinion in Oncology
|February 18, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A practical, adaptive compliance management framework for improving marine protected area effectiveness.

Conservation biology : the journal of the Society for Conservation Biology·2026
Same author

The effect of DNA recovery on the subsequent quality of latent fingermarks: A pseudo-operational trial.

Forensic science international·2019
Same author

Prevention of postsurgical wound dehiscence after abdominal surgery with NPWT: a multicentre randomised controlled trial protocol.

Journal of wound care·2017
Same author

Compliance of post-radiation therapy head and neck cancer patients with caries preventive protocols.

Australian dental journal·2016
Same author

Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study.

BMJ open·2016
Same author

Differences in the use of vision and proprioception for postural control in autism spectrum disorder.

Neuroscience·2015
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Phosphatases regulate cell processes, antagonizing kinases. While kinases are key in cancer, phosphatases like PTEN and protein phosphatase 2A act as tumor suppressors, whereas CDC25A/B are oncogenes.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Oncology

Background:

  • Kinase roles in cancer are well-established, but phosphatase involvement remains less understood.
  • Phosphatases are critical regulatory enzymes counteracting kinase activity in cellular signaling.
  • Understanding phosphatase function is crucial for cancer research and therapeutic development.

Purpose of the Study:

  • To review the current understanding of phosphatases in cancer etiology.
  • To highlight the distinct roles of specific phosphatases in tumor development.
  • To emphasize the need for further research into phosphatase functions in oncology.

Main Methods:

  • Literature review and synthesis of existing research on phosphatases and cancer.
  • Analysis of the known functions of protein phosphatase 2A, CDC25A/B, and PTEN in tumorigenesis.

Related Experiment Videos

  • Categorization of phosphatases based on their oncogenic or tumor-suppressive activities.

    • Main Results:

    • Three key phosphatases implicated in cancer: protein phosphatase 2A, CDC25A/B, and PTEN (MMAC1).
    • Protein phosphatase 2A and PTEN function as tumor suppressors, inhibiting cancer progression.
    • CDC25A and CDC25B act as oncogenes, promoting tumor development.

    Conclusions:

    • Phosphatases play critical, often opposing, roles in cancer development.
    • PTEN and protein phosphatase 2A represent potential therapeutic targets for cancer treatment.
    • CDC25A/B phosphatases are oncogenes and may be targets for anti-cancer therapies.